Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 195,836 | 88,662 | 167,645 | 147,270 | 106,892 |
| Depreciation Amortization | 49,135 | 24,848 | 95,158 | 70,744 | 47,307 |
| Income taxes - deferred | 1,537 | 285 | -44,981 | -20,137 | -5,108 |
| Accounts receivable | -56,081 | -3,386 | -190,435 | -131,940 | -145,831 |
| Other Working Capital | -172,307 | -105,386 | -336,539 | -239,423 | -279,342 |
| Other Operating Activity | 147,613 | 41,948 | 468,411 | 305,262 | 272,212 |
| Operating Cash Flow | $165,733 | $46,971 | $159,259 | $131,776 | $-3,870 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 122,187 | 9,868 | -3,633 | 24,634 | 47,014 |
| PPE Investments | -37,431 | -16,104 | -96,691 | -67,774 | -46,039 |
| Purchase Sale Intangibles | -8,512 | -8,000 | -10,920 | -3,141 | -1,457 |
| Other Investing Activity | -8,512 | -8,000 | -10,920 | -3,141 | -1,457 |
| Investing Cash Flow | $76,244 | $-14,236 | $-111,244 | $-46,281 | $-482 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,635 |
| Common Stock Issued | 36,618 | 7,197 | 69,353 | 54,548 | 50,193 |
| Other Financing Activity | -66,799 | -49,990 | -88,080 | -84,115 | -77,337 |
| Financing Cash Flow | $-30,181 | $-42,793 | $-18,727 | $-29,567 | $-28,779 |
| Exchange Rate Effect | 5,227 | 1,927 | 1,308 | 4,955 | 2,981 |
| Beginning Cash Position | 755,127 | 755,127 | 724,531 | 724,531 | 724,531 |
| End Cash Position | 972,150 | 746,996 | 755,127 | 785,414 | 694,381 |
| Net Cash Flow | $217,023 | $-8,131 | $30,596 | $60,883 | $-30,150 |
| Free Cash Flow | |||||
| Operating Cash Flow | 165,733 | 46,971 | 159,259 | 131,776 | -3,870 |
| Capital Expenditure | -47,431 | -26,104 | -96,691 | -67,774 | -46,039 |
| Free Cash Flow | 118,302 | 20,867 | 62,568 | 64,002 | -49,909 |